Bortezomib in combination with conventional chemotherapeutic agents for multiple myeloma compared with bortezomib alone.

Chang-Ki Min; Mi-Jin Lee; Ki-Seong Eom; Seok Lee; Jong-Wook Lee; Woo-Sung Min; Chun-Choo Kim; Myungshin Kim; Jihyang Lim; Yonggoo Kim

doi:10.1093/jjco/hym126

Bortezomib in combination with conventional chemotherapeutic agents for multiple myeloma compared with bortezomib alone.

Identifier:nobleid.org/w1/20260515/D8F0CEBC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D8F0CEBC.svg?ark=w1%2F20260515%2FD8F0CEBC)](https://nobleid.org/work/w1/20260515/D8F0CEBC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Bortezomib in combination with conventional chemotherapeutic agents for multiple myeloma compared with bortezomib alone.

Identifier:nobleid.org/w1/20260515/D8F0CEBC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D8F0CEBC.svg?ark=w1%2F20260515%2FD8F0CEBC)](https://nobleid.org/work/w1/20260515/D8F0CEBC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work